# Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma

> **NCT03945786** · — · SUSPENDED · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 120 (estimated)

## Conditions studied

- Endometrial Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03945786
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-06-03
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** Recuriting inclusion and exclusion criteria will be changed as COVID-19.
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945786, "Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03945786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*